-
2
-
-
78449265634
-
The eye as a common site for the early clinical manifestation of sarcoidosis
-
Heiligenhaus A, Wefelmeyer D, Wefelmeyer E, et al. The eye as a common site for the early clinical manifestation of sarcoidosis. Ophthalmic Res 2010; 46:9-12.
-
(2010)
Ophthalmic Res
, vol.46
, pp. 9-12
-
-
Heiligenhaus, A.1
Wefelmeyer, D.2
Wefelmeyer, E.3
-
4
-
-
77953325775
-
The sarcoid-tuberculosis link: Evidence from a high TB prevalence country
-
Mootha VK, Agarwal R, Aggarwal AN, et al. The sarcoid-tuberculosis link: evidence from a high TB prevalence country. J Infect 2010; 60:501-503.
-
(2010)
J Infect
, vol.60
, pp. 501-503
-
-
Mootha, V.K.1
Agarwal, R.2
Aggarwal, A.N.3
-
5
-
-
78549273717
-
Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis
-
Oswald-Richter KA, Beachboard DC, Zhan X, et al. Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis. Respir Res 2010; 11:161.
-
(2010)
Respir Res
, vol.11
, pp. 161
-
-
Oswald-Richter, K.A.1
Beachboard, D.C.2
Zhan, X.3
-
7
-
-
77955073714
-
Update on bioagent therapy in sarcoidosis
-
Cottin V. Update on bioagent therapy in sarcoidosis. F1000 Med Rep 2010; 24:2.
-
(2010)
F1000 Med Rep
, vol.24
, pp. 2
-
-
Cottin, V.1
-
8
-
-
77957743735
-
Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups
-
Sato H, Woodhead FA, Ahmad T, et al. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 2010; 19:4100-4111.
-
(2010)
Hum Mol Genet
, vol.19
, pp. 4100-4111
-
-
Sato, H.1
Woodhead, F.A.2
Ahmad, T.3
-
9
-
-
76149085883
-
CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis
-
Sato H, Williams HR, Spagnolo P, et al. CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis. Eur Respir J 2010; 35:324-330.
-
(2010)
Eur Respir J
, vol.35
, pp. 324-330
-
-
Sato, H.1
Williams, H.R.2
Spagnolo, P.3
-
10
-
-
20144388906
-
Sarcoidosis is associated with a truncating splice site mutation in BTNL2
-
Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 2005; 37:357-364.
-
(2005)
Nat Genet
, vol.37
, pp. 357-364
-
-
Valentonyte, R.1
Hampe, J.2
Huse, K.3
-
12
-
-
79751514055
-
The BTNL2 A allele variant is frequent in Danish patients with sarcoidosis
-
Milman N, Svendsen CB, Nielsen FC, et al. The BTNL2 A allele variant is frequent in Danish patients with sarcoidosis. Clin Respir J 2011; 5:105-111.
-
(2011)
Clin Respir J
, vol.5
, pp. 105-111
-
-
Milman, N.1
Svendsen, C.B.2
Nielsen, F.C.3
-
14
-
-
50449095436
-
Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis
-
Hofmann S, Franke A, Fischer A, et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 2008; 40:1103-1106.
-
(2008)
Nat Genet
, vol.40
, pp. 1103-1106
-
-
Hofmann, S.1
Franke, A.2
Fischer, A.3
-
15
-
-
77957190663
-
First independent replication study confirms the strong genetic association of ANXA11 with sarcoidosis
-
Li Y, Pabst S, Kubisch C, et al. First independent replication study confirms the strong genetic association of ANXA11 with sarcoidosis. Thorax 2010; 65:939-940.
-
(2010)
Thorax
, vol.65
, pp. 939-940
-
-
Li, Y.1
Pabst, S.2
Kubisch, C.3
-
16
-
-
80052302284
-
Functional variant ANXA11 R230C: True marker of protection and candidate disease modifier in sarcoidosis
-
(in press)
-
Mrazek F, Stahelova A, Kriegova E, et al. Functional variant ANXA11 R230C: true marker of protection and candidate disease modifier in sarcoidosis. Genes Immun 2011 (in press).
-
(2011)
Genes Immun
-
-
Mrazek, F.1
Stahelova, A.2
Kriegova, E.3
-
17
-
-
77955039470
-
Review: Role of genetics in susceptibility and outcome of sarcoidosis
-
Grunewald J. Review: role of genetics in susceptibility and outcome of sarcoidosis. Semin Respir Crit Care Med 2010; 31:380-389.
-
(2010)
Semin Respir Crit Care Med
, vol.31
, pp. 380-389
-
-
Grunewald, J.1
-
18
-
-
17944372335
-
CARD15 mutations in Blau syndrome
-
DOI 10.1038/ng720
-
Miceli-Richard C, Lesage S, Rybojad M, et al. CARD15 mutations in Blau syndrome. Nat Genet 2001; 29:19-20. (Pubitemid 32801800)
-
(2001)
Nature Genetics
, vol.29
, Issue.1
, pp. 19-20
-
-
Miceli-Richard, C.1
Lesage, S.2
Rybojad, M.3
Prieur, A.-M.4
Manouvrier-Hanu, S.5
Hafner, R.6
Chamaillard, M.7
Zouali, H.8
Thomas, G.9
Hugot, J.-P.10
-
19
-
-
79956289017
-
Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation
-
Jimenez-Martinez MC, Cruz F, Groman-Lupa S, et al. Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation. Int J Immunogenet 2011; 38:233-242.
-
(2011)
Int J Immunogenet
, vol.38
, pp. 233-242
-
-
Jimenez-Martinez, M.C.1
Cruz, F.2
Groman-Lupa, S.3
-
20
-
-
43849093322
-
Mutation screening of the CARD15 gene in sarcoidosis
-
DOI 10.1111/j.1399-0039.2008.01043.x
-
Akahoshi M, Ishihara M, Namba K, et al. Mutation screening of the CARD15 gene in sarcoidosis. Tissue Antigens 2008; 71:564-567. (Pubitemid 351697246)
-
(2008)
Tissue Antigens
, vol.71
, Issue.6
, pp. 564-567
-
-
Akahoshi, M.1
Ishihara, M.2
Namba, K.3
Kitaichi, N.4
Ando, Y.5
Takenaka, S.6
Ishida, T.7
Ohno, S.8
Mizuki, N.9
Nakashima, H.10
Shirakawa, T.11
-
21
-
-
79952394861
-
Caspase recruitment domain 15 gene haplotypes in sarcoidosis
-
Pabst S, Golebiewski M, Herms S, et al. Caspase recruitment domain 15 gene haplotypes in sarcoidosis. Tissue Antigens 2011; 77:333-337.
-
(2011)
Tissue Antigens
, vol.77
, pp. 333-337
-
-
Pabst, S.1
Golebiewski, M.2
Herms, S.3
-
22
-
-
80054961510
-
A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1
-
(in press)
-
Hofmann S, Fischer A, Till A, et al. A genome-wide association study reveals evidence of association with sarcoidosis at 6p12.1. Eur Respir J (in press).
-
(2010)
Eur Respir J
, vol.28
-
-
Hofmann, S.1
Fischer, A.2
Till, A.3
Kiltz, U.4
Braun, J.5
-
23
-
-
79953772293
-
TNFa antagonists and sarcoidosis
-
Culver DA, Baughman RP. TNFa antagonists and sarcoidosis. QJM 2011; 104:374.
-
(2011)
QJM
, vol.104
, pp. 374
-
-
Culver, D.A.1
Baughman, R.P.2
-
24
-
-
83555166298
-
Cytokine modulators in the treatment of sarcoidosis
-
(in press)
-
Bargagli E, Olivieri C, Rottoli P. Cytokine modulators in the treatment of sarcoidosis. Rheumatol Int 2011 (in press).
-
(2011)
Rheumatol Int
-
-
Bargagli, E.1
Olivieri, C.2
Rottoli, P.3
-
25
-
-
49649098822
-
Efficacy of infliximab in extrapulmonary sarcoidosis: Results from a randomised trial
-
Judson MA, Baughman RP, Costabel U, et al. Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial. Eur Respir J 2008; 31:1189-1196.
-
(2008)
Eur Respir J
, vol.31
, pp. 1189-1196
-
-
Judson, M.A.1
Baughman, R.P.2
Costabel, U.3
-
26
-
-
60249097515
-
The treatment of lupus pernio: Results of 116 treatment courses in 54 patients
-
Stagaki E, Mountford WK, Lackland DT, et al. The treatment of lupus pernio: results of 116 treatment courses in 54 patients. Chest 2009; 135:468-476.
-
(2009)
Chest
, vol.135
, pp. 468-476
-
-
Stagaki, E.1
Mountford, W.K.2
Lackland, D.T.3
-
27
-
-
77954232611
-
Transmembrane TNF-alpha: Structure, function and interaction with anti-TNF agents
-
Horiuchi T, Mitoma H, Harashima S, et al. Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 2010; 49:1215-1228.
-
(2010)
Rheumatology (Oxford)
, vol.49
, pp. 1215-1228
-
-
Horiuchi, T.1
Mitoma, H.2
Harashima, S.3
-
28
-
-
62149112955
-
Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab
-
Marnane M, Lynch T, Scott J, et al. Steroid-unresponsive neurosarcoidosis successfully treated with adalimumab. J Neurol 2009; 256:139-140.
-
(2009)
J Neurol
, vol.256
, pp. 139-140
-
-
Marnane, M.1
Lynch, T.2
Scott, J.3
-
29
-
-
72449207653
-
Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: A case report
-
Patel SR. Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report. J Med Case Reports 2009; 3:8573.
-
(2009)
J Med Case Reports
, vol.3
, pp. 8573
-
-
Patel, S.R.1
-
30
-
-
77956698536
-
Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept
-
Field S, Regan AO, Sheahan K, et al. Recalcitrant cutaneous sarcoidosis responding to adalimumab but not to etanercept. Clin Exp Dermatol 2010; 35:795-796.
-
(2010)
Clin Exp Dermatol
, vol.35
, pp. 795-796
-
-
Field, S.1
Regan, A.O.2
Sheahan, K.3
-
31
-
-
84866233788
-
Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: A case study
-
(in press)
-
Lahmer T, Knopf A, Lanzl I, et al. Using TNF-alpha antagonist adalimumab for treatment for multisystem sarcoidosis: a case study. Rheumatol Int 2011 (in press).
-
(2011)
Rheumatol Int
-
-
Lahmer, T.1
Knopf, A.2
Lanzl, I.3
-
32
-
-
80052698838
-
Disfiguring annular sarcoidosis improved by adalimumab
-
Kaiser CA, Cozzio A, Hofbauer GF, et al. Disfiguring annular sarcoidosis improved by adalimumab. Case Rep Dermatol 2011; 3:103-106.
-
(2011)
Case Rep Dermatol
, vol.3
, pp. 103-106
-
-
Kaiser, C.A.1
Cozzio, A.2
Hofbauer, G.F.3
-
33
-
-
46449111363
-
Rituximab as a treatment alternative in sarcoidosis
-
Belkhou A, Younsi R, El Bouchti I, et al. Rituximab as a treatment alternative in sarcoidosis. Joint Bone Spine 2008; 75:511-512.
-
(2008)
Joint Bone Spine
, vol.75
, pp. 511-512
-
-
Belkhou, A.1
Younsi, R.2
El Bouchti, I.3
-
34
-
-
73449131467
-
Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFalpha blockade. Efficacy of rituximab, report of a single case
-
Dasilva V, Breuil V, Chevallier P, et al. Relapse of severe sarcoidosis with an uncommon peritoneal location after TNFalpha blockade. Efficacy of rituximab, report of a single case. Joint Bone Spine 2010; 77:82-83.
-
(2010)
Joint Bone Spine
, vol.77
, pp. 82-83
-
-
Dasilva, V.1
Breuil, V.2
Chevallier, P.3
-
35
-
-
77955445467
-
A case of neurosarcoidosis successfully treated with rituximab
-
Bomprezzi R, Pati S, Chansakul C, et al. A case of neurosarcoidosis successfully treated with rituximab. Neurology 2010; 75:568-570.
-
(2010)
Neurology
, vol.75
, pp. 568-570
-
-
Bomprezzi, R.1
Pati, S.2
Chansakul, C.3
-
36
-
-
77951529848
-
Therapeutic antibodies for autoimmunity and inflammation
-
Chan AC, Carter PJ. Therapeutic antibodies for autoimmunity and inflammation. Nat Rev Immunol 2010; 10:301-316.
-
(2010)
Nat Rev Immunol
, vol.10
, pp. 301-316
-
-
Chan, A.C.1
Carter, P.J.2
-
37
-
-
79960209969
-
Therapeutic targeting of the IL-12/23 pathways: Generation and characterization of ustekinumab
-
Benson JM, Sachs CW, Treacy G, et al. Therapeutic targeting of the IL-12/23 pathways: generation and characterization of ustekinumab. Nat Biotechnol 2011; 29:615-624.
-
(2011)
Nat Biotechnol
, vol.29
, pp. 615-624
-
-
Benson, J.M.1
Sachs, C.W.2
Treacy, G.3
-
38
-
-
33744960433
-
Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis
-
DOI 10.1089/jir.2006.26.400
-
Antoniou KM, Tzouvelekis A, Alexandrakis MG, et al. Upregulation of Th1 cytokine profile (IL-12, IL-18) in bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis. J Interferon Cytokine Res 2006; 26:400-405. (Pubitemid 43856688)
-
(2006)
Journal of Interferon and Cytokine Research
, vol.26
, Issue.6
, pp. 400-405
-
-
Antoniou, K.M.1
Tzouvelekis, A.2
Alexandrakis, M.G.3
Tsiligianni, I.4
Tzanakis, N.5
Sfiridaki, K.6
Rachiotis, G.7
Bouros, D.8
Siafakas, N.M.9
-
39
-
-
34548782230
-
Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers
-
Hata M, Sugisaki K, Miyazaki E, et al. Circulating IL-12 p40 is increased in the patients with sarcoidosis, correlation with clinical markers. Intern Med 2007; 46:1387-1393.
-
(2007)
Intern Med
, vol.46
, pp. 1387-1393
-
-
Hata, M.1
Sugisaki, K.2
Miyazaki, E.3
-
40
-
-
64549153588
-
Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis
-
Mroz RM, Korniluk M, Stasiak-Barmuta A, et al. Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. J Physiol Pharmacol 2008; 59 (Suppl 6):507-513.
-
(2008)
J Physiol Pharmacol
, vol.59
, Issue.SUPPL. 6
, pp. 507-513
-
-
Mroz, R.M.1
Korniluk, M.2
Stasiak-Barmuta, A.3
-
41
-
-
79251621675
-
Sarcoidosis is a Th1/Th17 multisystem disorder
-
Facco M, Cabrelle A, Teramo A, et al. Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax 2011; 66:144-150.
-
(2011)
Thorax
, vol.66
, pp. 144-150
-
-
Facco, M.1
Cabrelle, A.2
Teramo, A.3
|